Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer

Journal of the National Cancer Institute

Volumn 90, Issue 17, 1998, Pages 1278-1284

  Stern, Robert S ^a   Liebman, Elissa J ^a   Väkevä, Liisa ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSORALEN;

ARTICLE; BASAL CELL CARCINOMA; CANCER CELL; CANCER LOCALIZATION; CANCER RISK; CANCER THERAPY; COHORT ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; PROSPECTIVE STUDY; PSORIASIS; PUVA; RISK FACTOR; SQUAMOUS CELL CARCINOMA;

EID: 0032475426     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.17.1278     Document Type: Article

References (30)

1. Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med 1974;291:1207-11.
2. Dunnick JK, Forbes PD, Eustis SL, Hardisty JF, Goodman DG. Tumors of the skin in the HRA/Skh mouse after treatment with 8-methoxypsoralen and UVA radiation. Fundam Appl Toxicol 1991;16:92-102.
3. Stern RS, Laird N, Melski J, Parrish JA, Fitzpatrick TB, Bleich HL. Cutaneous squamous-cell carcinoma in patients treated with PUVA. N Engl J Med 1984;310:1156-61.
4. Stern RS, Laird N. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study. Cancer 1994;73:2759-64.
5. Lever LR, Farr PM. Skin cancer or premalignant lesions occur in half of high-dose PUVA patients. Br J Dermatol 1994;131:215-19.
6. Lindelof B, Sigurgeirsson B, Tegner E, Larko O, Johannesson A, Berne B, et al. PUVA and cancer: a large-scale epidemiological study Lancet 1991; 338:91-3.
7. Maier H, Schemper M, Ortel B, Binder M, Tanew A, Honigsmann H. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients. Dermatology 1996;193:185-91.
8. Gallagher RP, Hill GB, Bajdik CD, Fincham S, Coldman AJ, McLean DI, et al. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 1995;131: 157-63.
9. Gallagher RP, Hill GB, Bajdik CD, Coldman AJ, Fincham S, McLean DI, et al. Sunlight exposure, pigmentation factors, and risk of nonmelanocytic skin cancer. II. Squamous cell carcinoma. Arch Dermatol 1995;131: 164-9.
10. Gallagher RP, Ma B, McLean DI, Yang CP, Ho V, Carruthers JA, et al. Trends in basal cell carcinoma, squamous cell carcinoma, and melanoma of the skin from 1973 through 1987. J Am Acad Dermatol 1990;23: 413-21.
11. Giles GG, Marks R, Foley P. Incidence of non-melanocytic skin cancer treated in Australia. Br Med J (Clin Res Ed) 1988;290:13-7.
12. Magnus K. The Nordic profile of skin cancer incidence. A comparative epidemiological study of the three main types of skin cancer. Int J Cancer 1991;47:12-9.
13. Scotto J, Fears TR, Fraumeni JF Jr. Incidence of non-melanoma skin cancer in the United States. Bethesda (MD): National Institutes of Health, National Cancer Institute; 1983 Report No.: DHHS Publ No. (NIH)82-2433.
14. STATA reference manual, version 5. College Station (TX): Stata Press; 1997.
15. Stern RS, Lange R. Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment [published erratum appears in J Invest Dermatol 1989;92:300]. J Invest Dermatol 1988;91: 120-4.
16. Chuang TY, Heinrich LA, Schultz MD, Reizner GT, Kumm RC, Cripps DJ. PUVA and skin cancer. A historical cohort study on 492 patients. J Am Acad Dermatol 1992;26:173-7.
17. Forman AB, Roenigk HH Jr, Caro WA, Magid ML. Long-term follow-up of skin cancer in the PUVA-48 cooperative study. Arch Dermatol 1989; 125:515-9.
18. Henseler T, Christophers E, Honigsmann H, Wolff K. Skin tumors in the European PUVA Study. Eight-year follow-up of 1,643 patients treated with PUVA for psoriasis. J Am Acad Dermatol 1987;16:108-16.
19. McKenna KE, Patterson CC, Handley J, McGinn S, Allen G. Cutaneous neoplasia following PUVA therapy for psoriasis. Br J Dermatol 1996;134: 639-42.
20. Torinuki W, Tagami H. Incidence of skin cancer in Japanese psoriatic patients treated with either methoxsalen phototherapy, Goeckerman regimen, or both therapies. A 10-year follow-up study. J Am Acad Dermatol 1988;18:1278-81.
21. Reshad H, Challoner F, Pollock DJ, Baker H. Cutaneous carcinoma in psoriatic patients treated with PUVA. Br J Dermatol 1984;110: 299-305.
22. Stern RS, Thibodeau LA, Kleinerman RA, Parrish JA, Fitzpatrick TB. Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. N Engl J Med 1979;300:809-13.
23. Bruynzeel I, Bergman W, Hartevelt HM, Kenter CCA, van de Velde EA, Schothorst AA, et al. 'High single-dose' European PUVA regimen also causes an excess of non-melanoma skin cancer. Br J Dermatol 1991;124: 49-55.
24. Stern RS, Nichols KT, Vakeva LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study. N Engl J Med 1997; 336: 1041-5.
25. Morison WL. Effects of ultraviolet radiation on the immune system in humans. Photochem Photobiol 1989;50:515-24.
26. Bouwes Bavinck JN, Vermeer BJ, van der Woude FJ, Vandenbroucke JP, Schreuder GMT, Thorogood J, et al. Relation between skin cancer and HLA antigens in renal transplant recipients. N Engl J Med 1991;325: 843-8.
27. Klecak G, Urbach F, Urwyler H. Fluoroquinolone antibacterials enhance UVA-induced skin tumors. J Photochem Photobiol B 1997;37:174-81.
28. Morison WL, Wimberly J, Parrish JA, Bloch KJ. Abnormal lymphocyte function following long-term PUVA therapy for psoriasis. Br J Dermatol 1983;108:445-50.
29. Stern RS, Nichols KT, Therapy with orally administered methoxsalen and ultraviolet A radiation during childhood increases the risk of basal cell carcinoma. The PUVA follow-up Study. J Pediatr 1996; 129: 915-7.
30. Stern RS. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The Photochemotherapy Follow-up Study. N Engl J Med 1990;322:1093-7.